Details of the Drug Reposition

General Information of This Drug (ID: DM45MR0)

Drug Name	HIP-2B DM45MR0

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Type-1/2 diabetes	DISIUHAP	5A10-5A11	Phase 1	[1]
Type-2 diabetes	DIS3X247	5A11	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01933256) Study of Subcutaneous Doses of HIP2B in Subjects With Type 2 Diabetes Mellitus Treated With Metformin. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)